University of Pittsburgh Health Sciences eLearning Environment Internet-based Studies in Education and Research
INTRODUCTION
5/11/2021 - Medical Grand Rounds: Evidence based kidney protection in Type 2 Diabetes & beyond
QUIZ
EVALUATION
CERTIFICATE
Credit Hours: CME 1.00
Faculty, residents, fellows, and community physicians in General Internal Medicine and subspecialties.
Upon completion of this activity, participants should be able to:
- Evaluate the prognosis for patients with kidney failure requiring dialysis and ways to improve their outcomes
- Describe causes of ESKD
- Explore ways to increase utilization of proven therapies and define additional protective therapies
- Review ways to prevent kidney failure with RAS blockade and SGLT2 inhibitors in patients with and without T2DM
Suggested additional reading:
- Mayer JB, et.al. Kidney Int 2019;96:489–504 and supplementary appendix
- SV Arnold et al. Circulation. 2019;140:618-620.
- Bakris GL, et al. N Engl J Med 2020. doi: 10.1056/NEJMoa2025845
- Agarwal R, et al. Eur Heart J 2020. In Press
- Bakris GL, et al. JAMA 2015;314:884.
- Bakris GL, et al. Am J Nephrol 2019;50:333
- Perkovic V et al. N Engl J Med 2019;Epub ahead of print doi: 10.1056/NEJMoa1811744
- Heerspink HJL. et al. Nephrol Dial Transplant. 2020 Feb 1;35(2):274-282
- Wheeler DC. et al. Nephrol Dial Transplant. 2020 DOI 10.1093/ndt/gfaa234
Joint Accreditation Statement
In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME) and the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
The University of Pittsburgh School of Medicine designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 Credit[s]™. Physicians should only claim credit commensurate with the extent of their participation in the activity. This educational activity is approved for 1.0 contact hours.
Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.
University of New South Wales, Sydney, Australia
Steering Comm & Presenter/advisory board: Nat Health & Med Res. Council of Australia, Janssen,Abbvie, Bayer, GSK, Boehringer Ingelheim, Lilly, Gilead, Novartis, Novo Nordisk, Retrophin/Travere, Tricida, & Pfizer. Presenter/advisory board: Amgen, Astra Zeneca, Baxter, Durect, Merck, Mitsubishi Tanabe, Mundipharma, Pharmalink, Reata, Relypsa, Roche, Sanofi, & Servier. Board Director: George Clinical Instit, Garvan Instit, Mindgardens Network, Childrens Cancer Instit, Victor Chang Cardiac Res. Inst
The University of Pittsburgh is an affirmative action, equal opportunity institution.